Assessing the Tolerability of Oligosaccharide Supplementation in Patients With Crohn's Disease

NATerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

September 30, 2020

Study Completion Date

September 30, 2020

Conditions
Crohn's Disease
Interventions
DIETARY_SUPPLEMENT

Placebo

1 placebo muesli bar and 1 serving placebo muesli per day (0.55 g total fructans/GOS)

DIETARY_SUPPLEMENT

Moderate Oligosaccharide Group

1 placebo muesli bar and 1 serving intervention muesli per day (3.25 g total fructans/GOS)

DIETARY_SUPPLEMENT

High Oligosaccharide Group

1 placebo muesli bar and 1 serving placebo muesli per day (5.43 g total fructans/GOS)

Trial Locations (2)

Unknown

Department of Gastroenterology Alfred Hospital, Melbourne

V6Z 1Y6

GI Clinic, St. Paul's Hospital, Vancouver

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

The Alfred

OTHER

collaborator

Melbourne Health

OTHER

lead

University of British Columbia

OTHER